Palvella Therapeutics PVLA
NASDAQ PVLA
$168.71 -5.37 (-3.08%)
At close: Nov 10, 2026 · 4:00 PM EST

Palvella Therapeutics (PVLA) EV to EBITDA (2024)

Updated

Palvella Therapeutics' (PVLA) EV to EBITDA came in at 0.73 for Q3 2024.

Analysis

Palvella Therapeutics (PVLA) EV to EBITDA (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Palvella Therapeutics 2.38 Bn 2.13 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 0.73
Mar 31, 2024 0.07
API Access

Palvella Therapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=PVLA&period=max&api_key=YOUR_API_KEY